Pontifax backs UK gene editing company in $10 million A round

Tropic Biosciences is developing decaffeinated coffee varieties and bananas with a longer shelf life using CRISPR gene editing technology that Pontifax managing partner Ben Belldegrun tells Agri Investor is drawing biotech investors into the market.

To view this content you must sign in:

Not yet registered? Join today to access Agri Investor's industry insights and updates.